Welcome to our dedicated page for United States Antimony SEC filings (Ticker: UAMY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
United States Antimony Corporation filings document the public-company record for an antimony, zeolite and critical-minerals producer and processor. Recent 8-K reports cover operating and financial results, conference-call materials, officer and finance-leadership changes, and operational updates tied to the Fostung tungsten property and its Technical Report Summary.
The company’s proxy materials describe annual-meeting voting matters and shareholder governance procedures. Its Form 25 records the withdrawal of common stock from NYSE American following the completed transfer of the listing to the New York Stock Exchange, while later current reports identify UAMY common stock as listed on the NYSE and NYSE Texas. The filings also disclose the company’s common stock class, par value, reporting status, and material-event exhibits.
United States Antimony Corp Chairman and CEO Gary C. Evans reported four issuer dispositions of Common Stock on March 25, 2026, totaling 400,000 shares at prices between 9.76 and 9.88 per share. After these transactions, he directly owns 2,231,951 shares.
US Antimony (UAMY) submitted a Form 144 reporting proposed sales of common stock. The filing lists two restricted common share entries of 66,667 shares dated 03/03/2025 and 05/15/2024 and reports 30,000 shares sold during the past three months on 03/25/2026.
The notice names Merrill (address shown) as the broker and indicates the securities trade on the NYSE. The filing is a routine notification of proposed or recent dispositions of restricted common stock.
UAMY proposed multiple open-market sales of Common Stock via Form 144, listing sale blocks on December 6–9 and December 12–13, 2022. The excerpt shows individual proposed sale amounts of 40,000, 251,281, 51,653 and 57,066 shares on those dates.
UNITED STATES ANTIMONY CORP executive Jeffrey Russell Fink, VP and General Manager of BRZ, reported several dispositions of common stock back to the company. On March 23 and 25, 2026, he transferred a total of 34,055 shares to the issuer at prices between $8.91 and $10.00 per share. After these transactions, he directly owned 108,656 shares of common stock, indicating he retains a substantial equity position.
UAMY filed a Form 144 disclosing securities to be sold under Rule 144, listing 34,055 shares of common stock described as restricted stock vesting with a vesting date of 01/29/2026. The filing lists brokerage contact Merrill Edge with two entries showing 10,000 and related numeric fields dated 03/23/2026 and 03/25/2026.
UAMY affiliate filed a Form 144 reporting an intent to sell common stock. The filing lists 34,055 shares of restricted common stock tied to restricted stock vesting on 01/29/2026 and shows Merrill Edge as a broker address. The record includes entries dated 03/23/2026.
United States Antimony Corporation reported a breakout 2025 with sharp growth but still a net loss. Sales reached $39.3 million, up 163% year over year, while gross profit rose $6.4 million and gross margin improved from 23% to 25%.
The company recorded a net loss of $4.3 million versus $1.7 million in 2024, largely driven by $6.7 million of non-cash expenses, mainly stock-based compensation. Liquidity strengthened significantly, with cash, U.S. Treasuries and equity securities totaling $91.3 million at 2025 year-end, up from $18.2 million, and working capital of $44.6 million. Debt remained very low at $195,000.
Management highlighted two 5‑year sales contracts totaling about $354 million, including a sole‑source U.S. government antimony ingot contract now sized at $248 million and an industrial antimony contract of $106.7 million. They expect roughly $75 million of antimony ingot deliveries in fiscal 2026 and guided to $125 million of 2026 revenue.
The company became fully vertically integrated in its Antimony Division, expanded ore sources, and is tripling capacity at the Thompson Falls smelter. It is also developing a new hydrometallurgical facility in Idaho with Americas Gold and Silver and received a $27 million USDOW award to help fund expansion.
On the resource side, US Antimony advanced multiple critical mineral projects. At the Fostung tungsten project in Ontario, an independent S‑K 1300 technical report estimated an inferred mineral resource of 14.77 million metric tons grading 0.17% WO₃, containing 54.17 million pounds of tungsten, with a stated future value of about $4.6 billion based on recent pricing. In Alaska, the company acquired the Nolan Creek property with a prior reserve estimate of 42,400 tons grading 28% antimony and 0.408 ounces of gold per ton, with an in‑situ metal value described as close to $7,000 per ton, implying roughly $297 million of metal value at stated prices.
Management emphasized rapid development at Stibnite Hill in Montana, where about 800 tons of 10% antimony ore were mined and trucked in 2025, and indicated plans to restart mining after winter. They also noted elevated antimony inventory of 465 tons at year-end, up from 78 tons, to support government contract deliveries.
Bear River Zeolite, the company’s zeolite division, is being repositioned under new leadership to focus on water treatment and agriculture. Water treatment currently represents about 75% of its revenue, and the operation benefits from a previously filed reserve report indicating an estimated 400‑year reserve life of high-quality zeolite. Management is pursuing more bulk business, infrastructure upgrades, and long-term supply contracts to improve margins and scale.
Investor relations reported a major shift in the shareholder base. The share price increased from $1.78 to $5.02 during 2025, with market capitalization rising from $201 million to $703 million. Institutional holders grew from 48 to 222, with approximately 40% institutional ownership and average daily trading volume near 15 million shares. The company also uplisted to the NYSE main board and highlighted its positioning as a domestic critical minerals supplier aligned with U.S. national security priorities.